Nearly 130 healthcare groups are urging Congress to pass legislation that would provide relief to U.S. physicians struggling to keep up with wave after wave of payment reductions.

While JenaValve is known for its Trilogy Heart Valve System, a device designed specifically to treat aortic regurgitation, Endotronix specializes in developing heart failure technologies. The news comes after Edwards sold its critical care business for $4.2 billion in June, saying it would double down on its structural heart portfolio. 

Businesses in the cardiovascular health space have been busy in recent weeks, announcing one big financing round after another. 

While 16% of male cardiologists have a net worth of more than $5 million, the same is true for just 6% of female cardiologists.

Magenta Medical plans to use some of the new financing to secure FDA approval for its Elevate LVAD. Novo Holdings, the controlling shareholder of international healthcare company Novo Nordisk, led the funding round.

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

The American Society of Nuclear Cardiology explored some key points included in the 2025 Medicare Physician Fee Schedule proposed rule.

Edwards, an early investor when the company first launched in 2017, said the acquisition will ensure its TMVR platform reaches as many patients as possible.